home / stock / dtc:cc / dtc:cc news

DTC:CC News and Press, Defence Therapeutics Inc. Class A

Stock Information
Company Name: Defence Therapeutics Inc. Class A
Stock Symbol: DTC:CC
Market: CNQC
Website: defencetherapeutics.com
Menu
DTC:CC DTC:CC Quote DTC:CC Short DTC:CC News DTC:CC Articles DTC:CC Message Board
Get DTC:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
DTC:CC - Defence Receives No Objection Letter from Health Canada for Phase I Trial of Its ACCUM-002 (AccuTOX) as an Anti-Cancer Molecule in Patients with Melanoma

Vancouver, British Columbia--(Newsfile Corp. - July 8, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce that it...
DTC:CC - Defence's AccuTOX Boosts and Synergizes with Immune Checkpoint Inhibitors

Vancouver, British Columbia--(Newsfile Corp. - June 28, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is please to announce that De...

DTC:CC - Canadian Companies Moving the Markets, Evening edition
Thu, Jun 27, 2024 as of 4:00 pm ET

A look at the top 10 most actives in Canada BlackBerry Limited (BB) rose 10.5% to $3.36 on volume of 12,209,225 shares Solstice Gold Corp. (SGC) fell 33.3% to $0.02 on volume of 11,588,936 shares HIGH INTEREST SAVINGS ACCOUNT FUND (HISA) fell 0.3% to $50.01 on volume of 10,628,355 shares ...

DTC:CC - Canadian Companies Moving the Markets, Morning edition
Thu, Jun 27, 2024 as of 10.00 am ET

A look at the top 10 most actives in Canada BlackBerry Limited (BB) rose 10.9% to $3.37 on volume of 2,461,797 shares Power Corporation of Canada Subordinate Voting Shares (POW) rose 0.4% to $38.46 on volume of 2,135,398 shares Alaris Equity Partners Income Trust 5.50% convertible unsecur...
DTC:CC - Defence's ARM-X Anti-Cancer Vaccine Inhibits Growth of Pre-Established Ovarian Cancer Resulting in Complete Responses in Treated Animals

Vancouver, British Columbia--(Newsfile Corp. - June 25, 2024) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce th...

DTC:CC - Defence's Chief Scientific Officer Dr. Moutih Rafei Discusses the Accum Platform for Cancer Treatments on Money Talk Radio with Ellis Martin

Vancouver, British Columbia--(Newsfile Corp. - June 17, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is please to share the interv...

DTC:CC - Ellis Martin Report: Defence Therapeutics Inc. (DTCFF) Dr. Moutih Rafei-Developing Vaccines and Platform Technologies for the Treatment of Cancer

Malibu, CA, United States (ABN Newswire) - Join Ellis Martin and Money Talk Radio for a conversation with Dr. Moutih Rafei, Chief Science Officer of Defence Therapeutics Inc. (CNSX:DTC) (FRA:DTC) (OTCMKTS:DTCFF). Defence Therapeutics is a publicly traded biotechnology company working on engin...
DTC:CC - Defence to Participate in 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto on June 11, 2024

Vancouver, British Columbia--(Newsfile Corp. - June 10, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is please to announce its pa...

DTC:CC - Defence's AccuTOX Published in the Prestigious Journal of Translational Medicine Its Peer Study with Preclinical Data on AccuTOX as an Anti-Cancer Molecule

Vancouver, British Columbia--(Newsfile Corp. - June 6, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is please to announce the p...

DTC:CC - Defence Therapeutics Strengthens and Expands Global Patent Protection on Key Technologies

Vancouver, British Columbia--(Newsfile Corp. - May 14, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce the...
Next 10